Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Physicians’ and nurses’ experience of using the Abbey Pain Scale (APS) in people with advanced cancer: a qualitative content analysis
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.ORCID iD: 0000-0002-0125-629X
Umeå University, Faculty of Medicine, Department of Nursing.ORCID iD: 0000-0002-1248-5581
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.ORCID iD: 0000-0003-4126-2675
2023 (English)In: BMC Nursing, E-ISSN 1472-6955, Vol. 22, no 1, article id 95Article in journal (Refereed) Published
Abstract [en]

Background: The Abbey Pain Scale (APS), an observational scale used to assess pain in people with end-stage dementia, is also widely used in Sweden to assess pain in patients with advanced cancer. It is unclear whether the APS is appropriate in this context. This study aims to explore physicians’ and nurses’ experiences of using a Swedish translation of the APS (the APS-SE) in people with advanced cancer.

Methods: Conventional qualitative content analysis was used to analyse interviews with physicians (n = 6) and nurses (n = 6) working in oncology and specialised palliative care about their experiences of using the APS-SE.

Results: Three categories were created: fills a need, not always on target, and does not fully suit the clinical situation. Participants reported that although the APS-SE provides support in a challenging situation, it sometimes misses the mark: it does not distinguish well between pain and other types of suffering and its pain score tends not to reflect professionals’ intuitive perceptions of patients’ suffering. Some parts of the APS-SE were not considered useful, and others were perceived as ethically questionable.

Conclusion: Health professionals greatly need an observational pain assessment tool for people with advanced cancer. The APS-SE is helpful in this context, but participants did not perceive it as ideal. Its problems seem inherent to the original APS rather than related to its translation from English to Swedish. Further research is needed to provide a more suitable pain assessment tool for patients with advanced cancer.

Place, publisher, year, edition, pages
BioMed Central (BMC), 2023. Vol. 22, no 1, article id 95
Keywords [en]
Abbey Pain Scale, Cancer, End-of-life care, Pain assessment, Palliative care, Qualitative content analysis
National Category
Nursing
Identifiers
URN: urn:nbn:se:umu:diva-206951DOI: 10.1186/s12912-023-01227-7ISI: 000962672100002Scopus ID: 2-s2.0-85152708199OAI: oai:DiVA.org:umu-206951DiVA, id: diva2:1753363
Funder
Cancerforskningsfonden i Norrland, AMP 18-922Region Västerbotten, 7003533Available from: 2023-04-26 Created: 2023-04-26 Last updated: 2024-07-04Bibliographically approved
In thesis
1. Pain or no pain? That is the question: an evaluation of the observational pain assessment instrument Abbey Pain Scale in patients with cancer
Open this publication in new window or tab >>Pain or no pain? That is the question: an evaluation of the observational pain assessment instrument Abbey Pain Scale in patients with cancer
2024 (English)Doctoral thesis, comprehensive summary (Other academic)
Alternative title[sv]
Smärta eller inte smärta? Det är frågan : en utvärdering av observationssmärtskattningsskalan Abbey Pain Scale vid användning hos patienter med cancer
Abstract [en]

Background: The Abbey Pain Scale (APS) is an observational pain assessment instrument that was created for use among patients with dementia. It is sometimes used in Sweden to assess pain in patients with advanced cancer who are unable to vocalize their pain, but it has never been evaluated in this population.

Aim: To evaluate observational pain assessment for people with advanced cancer in a palliative care setting, focusing on the APS.

Methods: The APS was translated and adapted into a Swedish dementia context through interviews with health care professionals (n=11). The resulting APS-SE was then used in a qualitative content analysis exploring health care professionals’ experience of using the instrument in patients with advanced cancer (n=12). The psychometrics of the APS-SE when used in patients with advanced cancer (n=72) were determined through test-retest and inter-rater reliability, internal consistency reliability, and responsiveness to opioids. Criterion validity was determined against the patients’ self-reported pain (n=45).

Results: The APS-SE was comprehensible by users within dementia care, regardless of their educational and linguistic background. The qualitative analysis revealed that when used in patients with advanced cancer, the APS-SE fulfilled the need for an observational pain assessment instrument, but was not always on target and did not fully suit the clinical situation. The psychometric analysis showed slight criterion validity (κ=0.08) and unacceptable internal consistency reliability (Cronbach’s α=0.01). The test-retest reliability was good (ICC=0.82) and the inter-rater reliability moderate (ICC=0.64), but the latter had a confidence interval ranging from poor to good. Responsiveness to opioids was demonstrated (p=0.01).

Conclusions: This thesis underscores the need for a specialized observational pain assessment instrument explicitly tailored for patients with advanced cancer. The current lack of a recognized alternative emphasizes the importance of developing such an instrument to address the critical gap in observational pain assessment in the palliative oncology setting.

Place, publisher, year, edition, pages
Umeå: Umeå University, 2024. p. 95
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 2296
Keywords
Abbey Pain Scale, APS-SE, cancer pain, observational pain assessment, advanced cancer, end-of-life care, palliative oncology
National Category
Cancer and Oncology Nursing
Research subject
Oncology
Identifiers
urn:nbn:se:umu:diva-223902 (URN)9789180703482 (ISBN)9789180703499 (ISBN)
Public defence
2024-06-05, Bergasalen, Norrlands universitetssjukhus, Umeå, 09:00 (Swedish)
Opponent
Supervisors
Available from: 2024-05-13 Created: 2024-04-30 Last updated: 2024-05-06Bibliographically approved

Open Access in DiVA

fulltext(867 kB)594 downloads
File information
File name FULLTEXT01.pdfFile size 867 kBChecksum SHA-512
7bb109677e1eea107495207c0592a21563210eb61092084136457aa74757e5c96d9ac49d1f96cb8b678e6a5154589776daa442d0c5a668b971214a036575c954
Type fulltextMimetype application/pdf

Other links

Publisher's full textScopus

Authority records

Tegenborg, SussiFransson, PerMartinsson, Lisa

Search in DiVA

By author/editor
Tegenborg, SussiFransson, PerMartinsson, Lisa
By organisation
OncologyDepartment of Nursing
In the same journal
BMC Nursing
Nursing

Search outside of DiVA

GoogleGoogle Scholar
Total: 594 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 767 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf